CD33 and hepatocellular carcinoma: In addition, we noted that PD-L1+ cells could also express CD33 (25.63 ± 6.50%), but rarely expressed CD11b (6.71 ± 1.92%), which indicated that PD-L1 could be expressed on different subpopulations of myeloid cells in HCC.